Sponsored diagnostic testing programs for Severe Combined Immunodeficiency (SCID)
Severe Combined Immunodeficiency (SCID) is a group of rare, inherited disorders marked by profoundly impaired T-cell and B-cell function, leaving the immune system unable to fight infections. Infants with SCID often develop severe, recurrent infections early in life and require prompt diagnosis and specialized treatment to prevent life-threatening complications.
2 programs found for Severe Combined Immunodeficiency (SCID)
Invitae Unlock™ Immunology provides clinicians with a comprehensive gene panel to evaluate patients with suspected primary immunodeficiency or immune-regulatory disorders. This no-charge program supports diagnostic clarification, aids in variant-guided care decisions, and can inform family cascade testing when appropriate.
Invitae Unlock Immunology offers sponsored access to the Inborn Errors of Immunity and Cytopenias Panel, Invitae’s most comprehensive assay for evaluating inherited immune disorders and cytopenias. The panel includes genes tied to combined immunodeficiencies, immune dysregulation, and bone marrow failure, supporting clearer diagnosis and management. U.S. providers may order for eligible patients.
